Biomaterials for the treatment of myocardial infarction.

Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials (2009) 2.41

Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26

Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nat Mater (2008) 2.05

Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg (2008) 1.82

Theoretic impact of infarct compliance on left ventricular function. Ann Thorac Surg (2009) 1.75

Modification of infarct material properties limits adverse ventricular remodeling. Ann Thorac Surg (2011) 1.72

Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med (2013) 1.69

The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68

Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol (2012) 1.60

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol Ther (2009) 1.45

Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo. J Thorac Cardiovasc Surg (2014) 1.44

Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A (2010) 1.39

Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology (2009) 1.37

Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges. Acta Biomater (2010) 1.33

Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res (2010) 1.28

A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro. Acta Biomater (2012) 1.27

Minimally invasive epicardial injections using a novel semiautonomous robotic device. Circulation (2008) 1.21

Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials (2012) 1.14

Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS One (2010) 1.10

Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med (2010) 1.08

Mesenchymal stem cells for vascular regeneration. Regen Med (2008) 1.06

Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction. PLoS One (2011) 1.06

Active contraction of cardiac muscle: in vivo characterization of mechanical activation sequences in the beating heart. J Mech Behav Biomed Mater (2011) 1.04

Surface-patterned electrode bioreactor for electrical stimulation. Lab Chip (2010) 1.03

Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction. Biomaterials (2012) 1.00

Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98

Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress. Stem Cells Transl Med (2014) 0.98

Biocompatible hydrogels by oxime Click chemistry. Biomacromolecules (2012) 0.97

Tailoring material properties of a nanofibrous extracellular matrix derived hydrogel. Nanotechnology (2011) 0.97

Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol Biosci (2011) 0.97

Regional mechanics determine collagen fiber structure in healing myocardial infarcts. J Mol Cell Cardiol (2012) 0.97

Infarct restraint to limit adverse ventricular remodeling. J Cardiovasc Transl Res (2010) 0.96

Cardiac tissue engineering. J Cardiovasc Nurs (2009) 0.96

Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med (2009) 0.95

Design of electrical stimulation bioreactors for cardiac tissue engineering. Conf Proc IEEE Eng Med Biol Soc (2008) 0.95

Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol (2012) 0.95

From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater (2015) 0.94

Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration. Tissue Eng Part A (2012) 0.94

Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev (2010) 0.93

Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. J Cardiovasc Transl Res (2014) 0.93

Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92

Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail (2013) 0.92

Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine (2012) 0.91

Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat Clin Pract Cardiovasc Med (2009) 0.90

Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds. J Biomed Mater Res A (2011) 0.88

Materials science and tissue engineering: repairing the heart. Mayo Clin Proc (2013) 0.87

Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One (2012) 0.84

Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res (2010) 0.84

Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor. Tissue Eng Part A (2012) 0.83

Engineered myocardial tissues constructed in vivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats. J Biomed Sci (2012) 0.82

The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation. Biomaterials (2014) 0.82

Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats. Stem Cells Transl Med (2012) 0.82

Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction. PLoS One (2015) 0.82

Design of a 3D aligned myocardial tissue construct from biodegradable polyesters. J Mater Sci Mater Med (2009) 0.81

Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels (2015) 0.81

Greater cardiomyocyte density on aligned compared with random carbon nanofibers in polymer composites. Int J Nanomedicine (2014) 0.81

Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med (2013) 0.80

The potential of stem cells in the treatment of cardiovascular diseases. Stem Cell Rev (2013) 0.80

Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair. Stem Cells Transl Med (2013) 0.80

Development of a Cyclic Strain Bioreactor for Mechanical Enhancement and Assessment of Bioengineered Myocardial Constructs. Cardiovasc Eng Technol (2015) 0.79

Electrospun PLGA fibers incorporated with functionalized biomolecules for cardiac tissue engineering. Tissue Eng Part A (2014) 0.78

Cardiac tissue engineering and regeneration using cell-based therapy. Stem Cells Cloning (2015) 0.78

Oxime cross-linked injectable hydrogels for catheter delivery. Adv Mater (2013) 0.78

New strategies for improving stem cell therapy in ischemic heart disease. Heart Fail Rev (2016) 0.77

Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair. Stem Cells Transl Med (2016) 0.77

Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int J Nanomedicine (2012) 0.77

Improving Cell Engraftment in Cardiac Stem Cell Therapy. Stem Cells Int (2015) 0.76

Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment. Stem Cells Int (2016) 0.76

Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling. J Mater Sci Mater Med (2011) 0.76

Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review. Int J Mol Cell Med (2012) 0.75

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart. J Vis Exp (2015) 0.75

Human iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac Regeneration. Curr Treat Options Cardiovasc Med (2016) 0.75

Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation. Acta Biomater (2015) 0.75

Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) (2017) 0.75

A regenerative cardiac patch formed by spray painting of biomaterials onto the heart. Tissue Eng Part C Methods (2017) 0.75

Genesis of myocardial repair with cardiac progenitor cells and tissue engineering. Heart Asia (2010) 0.75

Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine. Adv Healthc Mater (2015) 0.75

Human heart valve-derived scaffold improves cardiac repair in a murine model of myocardial infarction. Sci Rep (2017) 0.75

Understanding greater cardiomyocyte functions on aligned compared to random carbon nanofibers in PLGA. Int J Nanomedicine (2014) 0.75

Functional analysis of the engineered cardiac tissue grown on recombinant spidroin fiber meshes. PLoS One (2015) 0.75

Thermosensitive and Highly Flexible Hydrogels Capable of Stimulating Cardiac Differentiation of Cardiosphere-Derived Cells under Static and Dynamic Mechanical Training Conditions. ACS Appl Mater Interfaces (2016) 0.75

Regional assessment of in vivo myocardial stiffness using 3D magnetic resonance elastography in a porcine model of myocardial infarction. Magn Reson Med (2017) 0.75

Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium. Exp Ther Med (2017) 0.75

Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol (2004) 3.44

Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol (2012) 3.12

Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985) (2007) 2.52

Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng (2004) 2.42

Myotube assembly on nanofibrous and micropatterned polymers. Nano Lett (2006) 2.00

Intracardiac and extracardiac markers of inflammation during atrial fibrillation. Heart Rhythm (2009) 2.00

Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm (2010) 1.89

Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm (2006) 1.84

Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm (2007) 1.82

Postresuscitation stunning: postfibrillatory myocardial dysfunction caused by reduced myofilament Ca2+ responsiveness after ventricular fibrillation-induced myocyte Ca2+ overload. J Cardiovasc Electrophysiol (2002) 1.48

Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng (2006) 1.46

Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry. J Cardiovasc Electrophysiol (2010) 1.43

Predictors of axillary vein location for vascular access during pacemaker and defibrillator lead implantation. Pacing Clin Electrophysiol (2011) 1.42

The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39

Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2009) 1.21

The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials (2010) 1.20

Increases in P-wave dispersion predict postoperative atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg (2004) 1.19

The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials (2008) 1.17

Atrial tachycardia arising from the coronary sinus musculature: electrophysiological characteristics and long-term outcomes of radiofrequency ablation. J Am Coll Cardiol (2005) 1.16

A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc (2006) 1.16

A first-degree family history in lone atrial fibrillation patients. Heart Rhythm (2008) 1.14

Pinhole single-photon emission computed tomography for myocardial perfusion imaging of mice. J Am Coll Cardiol (2003) 1.12

Impact of remote magnetic catheter navigation on ablation fluoroscopy and procedure time. Pacing Clin Electrophysiol (2008) 1.07

Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation (2002) 1.06

Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology (2006) 1.05

Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.05

An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLoS One (2011) 1.05

Comparison of gene-transfer efficiency in human embryonic stem cells. Mol Imaging Biol (2009) 1.05

Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials (2005) 1.04

Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol (1985) (2008) 1.02

Alcohol intake is significantly associated with atrial flutter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol (2008) 0.99

Algisyl-LVR™ with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol (2013) 0.98

The new face of bispecific antibodies: targeting cancer and much more. Exp Hematol (2006) 0.97

Scarred myocardium imposes additional burden on remote viable myocardium despite a reduction in the extent of area with late contrast MR enhancement. Eur Radiol (2005) 0.96

Surface electrocardiographic characteristics of right and left atrial flutter. Circulation (2003) 0.94

Protracted CRP elevation after atrial fibrillation ablation. Pacing Clin Electrophysiol (2008) 0.93

Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med (2009) 0.93

Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering. Tissue Eng (2007) 0.92

Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail (2013) 0.92

Engineering of aligned skeletal muscle by micropatterning. Am J Transl Res (2010) 0.91

Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol (2008) 0.91

Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol (2014) 0.89

Protected circumferential conduction in the posterior atrioventricular vestibule of the left atrium: electrophysiologic and anatomic correlates. Pacing Clin Electrophysiol (2005) 0.89

The relative importance of left atrial function versus dimension in predicting atrial fibrillation after coronary artery bypass graft surgery. Am Heart J (2002) 0.89

Tissue engineering of muscle on micropatterned polymer films. Conf Proc IEEE Eng Med Biol Soc (2004) 0.89

Proteomic identification of biomarkers of vascular injury. Am J Transl Res (2010) 0.89

Pleiotrophin induces formation of functional neovasculature in vivo. Biochem Biophys Res Commun (2005) 0.89

High-resolution optical mapping of ventricular tachycardia in rats with chronic myocardial infarction. Pacing Clin Electrophysiol (2010) 0.88

Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction. PLoS One (2010) 0.87

Electrophysiologic properties of para-Hisian atrial tachycardia. Heart Rhythm (2011) 0.87

Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium. Blood Cells Mol Dis (2004) 0.86

The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model. Biomaterials (2013) 0.86

MR guidance of targeted injections into border and core of scarred myocardium in pigs. Radiology (2006) 0.84

Differences in accessory pathway location by sex and race. Heart Rhythm (2009) 0.83

The effect of polypyrrole on arteriogenesis in an acute rat infarct model. Biomaterials (2008) 0.83

Alcohol and vagal tone as triggers for paroxysmal atrial fibrillation. Am J Cardiol (2012) 0.83

Coupling interval dispersion and body mass index are independent predictors of idiopathic premature ventricular complex-induced cardiomyopathy. J Cardiovasc Electrophysiol (2014) 0.81

Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression. Acta Biomater (2010) 0.80

Shox2 regulates the pacemaker gene program in embryoid bodies. Stem Cells Dev (2013) 0.80

Tissue engineering and stem cell therapy for myocardial repair. Front Biosci (2007) 0.79

Virtual reality of stem cell transplantation to repair injured myocardium. J Cell Biochem (2005) 0.78

The Promise and Therapeutic Potential of Human ES and iPS Cells. Stem Cells Int (2011) 0.77

Predictors of unusual ECG characteristics in cavotricuspid isthmus-dependent atrial flutter ablation. Pacing Clin Electrophysiol (2011) 0.77

Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function. J Renin Angiotensin Aldosterone Syst (2003) 0.77

Using extracellular matrix-derived peptides to alter the microenvironment for myocardial repair. Curr Vasc Pharmacol (2012) 0.76

Remote navigation guided ablation of incessant atrial tachycardia in a patient with restricted venous access. J Cardiovasc Electrophysiol (2009) 0.76

Extracellular matrix-derived peptides and myocardial repair. Cell Adh Migr (2011) 0.76

Test characteristics of neck fullness and witnessed neck pulsations in the diagnosis of typical AV nodal reentrant tachycardia. Clin Cardiol (2009) 0.75

Pleiotrophin gene therapy for peripheral ischemia: evaluation of full-length and truncated gene variants. PLoS One (2013) 0.75

Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc (2013) 0.75

The effects of aging on apoptosis following myocardial infarction. Cardiovasc Ther (2013) 0.75

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Expert Rev Cardiovasc Ther (2015) 0.75

Surgical and concomitant epicardial-endocardial (hybrid) ablation of persistent and long-standing persistent atrial fibrillation. Curr Probl Cardiol (2015) 0.75

The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke. J Renin Angiotensin Aldosterone Syst (2002) 0.75

Usefulness of a ventricular extrastimulus from the summit of the ventricular septum in diagnosis of septal accessory pathway in patients with supraventricular tachycardia. Am J Cardiol (2004) 0.75